Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have reduced the opioid epidemic’s toll. Credit...Photo illustration by Ben Denzer ...

Taking medication for opioid use disorder “can offer an advantage, an often-needed edge,” says Miranda. “It can offer ...

Since the 1970s, countless experts and the US government have sold the public a simple explanation for drug addiction, now clinically called substance abuse disorder: the myth of the gateway drug.

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Young adults may suffer strokes when using cocaine, meth, and even cannabis, and the onset may be shortly after drug use and ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

Ms. Szalavitz is a contributing Opinion writer. Jessica Massarone couldn’t concentrate in primary school: She was too preoccupied with her parents’ struggles with drug addiction. Sometimes, she’d find ...

(NewsNation) — President Donald Trump signed an executive order on Thursday launching a new initiative to address drug addiction and substance abuse in the country. The “White House Great American ...